267 related articles for article (PubMed ID: 22704060)
1. Transient and intensive pharmacological immunosuppression fails to improve AAV-based liver gene transfer in non-human primates.
Unzu C; Hervás-Stubbs S; Sampedro A; Mauleón I; Mancheño U; Alfaro C; de Salamanca RE; Benito A; Beattie SG; Petry H; Prieto J; Melero I; Fontanellas A
J Transl Med; 2012 Jun; 10():122. PubMed ID: 22704060
[TBL] [Abstract][Full Text] [Related]
2. Helper-dependent adenovirus achieve more efficient and persistent liver transgene expression in non-human primates under immunosuppression.
Unzu C; Melero I; Hervás-Stubbs S; Sampedro A; Mancheño U; Morales-Kastresana A; Serrano-Mendioroz I; de Salamanca RE; Benito A; Fontanellas A
Gene Ther; 2015 Nov; 22(11):856-65. PubMed ID: 26125605
[TBL] [Abstract][Full Text] [Related]
3. Successful attenuation of humoral immunity to viral capsid and transgenic protein following AAV-mediated gene transfer with a non-depleting CD4 antibody and cyclosporine.
McIntosh JH; Cochrane M; Cobbold S; Waldmann H; Nathwani SA; Davidoff AM; Nathwani AC
Gene Ther; 2012 Jan; 19(1):78-85. PubMed ID: 21716299
[TBL] [Abstract][Full Text] [Related]
4. Safety and liver transduction efficacy of rAAV5-cohPBGD in nonhuman primates: a potential therapy for acute intermittent porphyria.
Pañeda A; Lopez-Franco E; Kaeppel C; Unzu C; Gil-Royo AG; D'Avola D; Beattie SG; Olagüe C; Ferrero R; Sampedro A; Mauleon I; Hermening S; Salmon F; Benito A; Gavira JJ; Cornet ME; del Mar Municio M; von Kalle C; Petry H; Prieto J; Schmidt M; Fontanellas A; González-Aseguinolaza G
Hum Gene Ther; 2013 Dec; 24(12):1007-17. PubMed ID: 24070415
[TBL] [Abstract][Full Text] [Related]
5. Modulation of tolerance to the transgene product in a nonhuman primate model of AAV-mediated gene transfer to liver.
Mingozzi F; Hasbrouck NC; Basner-Tschakarjan E; Edmonson SA; Hui DJ; Sabatino DE; Zhou S; Wright JF; Jiang H; Pierce GF; Arruda VR; High KA
Blood; 2007 Oct; 110(7):2334-41. PubMed ID: 17609423
[TBL] [Abstract][Full Text] [Related]
6. Intensive pharmacological immunosuppression allows for repetitive liver gene transfer with recombinant adenovirus in nonhuman primates.
Fontanellas A; Hervás-Stubbs S; Mauleón I; Dubrot J; Mancheño U; Collantes M; Sampedro A; Unzu C; Alfaro C; Palazón A; Smerdou C; Benito A; Prieto J; Peñuelas I; Melero I
Mol Ther; 2010 Apr; 18(4):754-65. PubMed ID: 20087317
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological modulation of humoral immunity in a nonhuman primate model of AAV gene transfer for hemophilia B.
Mingozzi F; Chen Y; Murphy SL; Edmonson SC; Tai A; Price SD; Metzger ME; Zhou S; Wright JF; Donahue RE; Dunbar CE; High KA
Mol Ther; 2012 Jul; 20(7):1410-6. PubMed ID: 22565846
[TBL] [Abstract][Full Text] [Related]
8. Transient immunosuppression allows transgene expression following readministration of adeno-associated viral vectors.
Manning WC; Zhou S; Bland MP; Escobedo JA; Dwarki V
Hum Gene Ther; 1998 Mar; 9(4):477-85. PubMed ID: 9525309
[TBL] [Abstract][Full Text] [Related]
9. Transient depletion of specific immune cell populations to improve adenovirus-mediated transgene expression in the liver.
Alzuguren P; Hervas-Stubbs S; Gonzalez-Aseguinolaza G; Poutou J; Fortes P; Mancheno U; Bunuales M; Olagüe C; Razquin N; Van Rooijen N; Enguita M; Hernandez-Alcoceba R
Liver Int; 2015 Apr; 35(4):1274-89. PubMed ID: 24754307
[TBL] [Abstract][Full Text] [Related]
10. Mycophenolate mofetil impairs transduction of single-stranded adeno-associated viral vectors.
Montenegro-Miranda PS; ten Bloemendaal L; Kunne C; de Waart DR; Bosma PJ
Hum Gene Ther; 2011 May; 22(5):605-12. PubMed ID: 21222531
[TBL] [Abstract][Full Text] [Related]
11. Successful Repeated Hepatic Gene Delivery in Mice and Non-human Primates Achieved by Sequential Administration of AAV5
Majowicz A; Salas D; Zabaleta N; Rodríguez-Garcia E; González-Aseguinolaza G; Petry H; Ferreira V
Mol Ther; 2017 Aug; 25(8):1831-1842. PubMed ID: 28596114
[TBL] [Abstract][Full Text] [Related]
12. Effects of transient immunosuppression on adenoassociated, virus-mediated, liver-directed gene transfer in rhesus macaques and implications for human gene therapy.
Jiang H; Couto LB; Patarroyo-White S; Liu T; Nagy D; Vargas JA; Zhou S; Scallan CD; Sommer J; Vijay S; Mingozzi F; High KA; Pierce GF
Blood; 2006 Nov; 108(10):3321-8. PubMed ID: 16868252
[TBL] [Abstract][Full Text] [Related]
13. Immunoadsorption enables successful rAAV5-mediated repeated hepatic gene delivery in nonhuman primates.
Salas D; Kwikkers KL; Zabaleta N; Bazo A; Petry H; van Deventer SJ; Aseguinolaza GG; Ferreira V
Blood Adv; 2019 Sep; 3(17):2632-2641. PubMed ID: 31501158
[TBL] [Abstract][Full Text] [Related]
14. Long-term expression and repeated administration of AAV type 1, 2 and 5 vectors in skeletal muscle of immunocompetent adult mice.
Rivière C; Danos O; Douar AM
Gene Ther; 2006 Sep; 13(17):1300-8. PubMed ID: 16688207
[TBL] [Abstract][Full Text] [Related]
15. In Utero Transfer of Adeno-Associated Viral Vectors Produces Long-Term Factor IX Levels in a Cynomolgus Macaque Model.
Mattar CNZ; Gil-Farina I; Rosales C; Johana N; Tan YYW; McIntosh J; Kaeppel C; Waddington SN; Biswas A; Choolani M; Schmidt M; Nathwani AC; Chan JKY
Mol Ther; 2017 Aug; 25(8):1843-1853. PubMed ID: 28462816
[TBL] [Abstract][Full Text] [Related]
16. Long-term persistence of gene expression from adeno-associated virus serotype 5 in the mouse airways.
Sumner-Jones SG; Davies LA; Varathalingam A; Gill DR; Hyde SC
Gene Ther; 2006 Dec; 13(24):1703-13. PubMed ID: 16855618
[TBL] [Abstract][Full Text] [Related]
17. Five Years of Successful Inducible Transgene Expression Following Locoregional Adeno-Associated Virus Delivery in Nonhuman Primates with No Detectable Immunity.
Guilbaud M; Devaux M; Couzinié C; Le Duff J; Toromanoff A; Vandamme C; Jaulin N; Gernoux G; Larcher T; Moullier P; Le Guiner C; Adjali O
Hum Gene Ther; 2019 Jul; 30(7):802-813. PubMed ID: 30808235
[TBL] [Abstract][Full Text] [Related]
18. Immune responses to AAV in clinical trials.
Mingozzi F; High KA
Curr Gene Ther; 2007 Oct; 7(5):316-24. PubMed ID: 17979678
[TBL] [Abstract][Full Text] [Related]
19. Immune responses to AAV in clinical trials.
Mingozzi F; High KA
Curr Gene Ther; 2011 Aug; 11(4):321-30. PubMed ID: 21557723
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxic T lymphocyte responses to transgene product, not adeno-associated viral capsid protein, limit transgene expression in mice.
Siders WM; Shields J; Kaplan J; Lukason M; Woodworth L; Wadsworth S; Scaria A
Hum Gene Ther; 2009 Jan; 20(1):11-20. PubMed ID: 18828728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
